Fitch A, Ingersoll AB
In a qualitative sense, moving from days/weeks to near-immediate decisions means patients can commence GLP-1 therapy sooner
In addition, less than 30% of patients remain on treatment for more than a year 6,7,8 , and treatment discontinuation typically results in rapid weight regain 4,9,10 , with the majority of this gain attributed to increases in fat mass 11,12,13
[3] The regulation of levels of ROS, levels of oxidized and reduced glutathione and other thiols, and antioxidant enzymes (such as GSTs and glutathione reductase) are important in determination of the most stable conditions for redox control, or for activation of apoptosis
That said, you must discuss your candidacy for this treatment with a qualified practitioner